Vivos Therapeutics, Inc. Payments of Debt Issuance Costs
Vivos Therapeutics, Inc. (VVOS) reported Payments of Debt Issuance Costs of $2.24 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2022-03-31
- Vivos Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2021-12-31 was $434.00.
- Vivos Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2021-09-30 was $3.50K.
- Vivos Therapeutics, Inc. payments of debt issuance costs for fiscal 2021 was $2.24M, a 813.47% increase from fiscal 2020.
- Vivos Therapeutics, Inc. payments of debt issuance costs for fiscal 2020 was $245.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $434.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $3.93K derived: sum of 2 quarters · filed 2022-03-31 | $2.24M 10-K · filed 2022-03-31 | |
| 2021-09-30 | $3.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.24M 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $2.23M 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $245.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |